[1]
Duconge J, Santiago E, Hernandez-Suarez DF, et al. Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach. Clin Transl Sci 2021 11; 14(6): 2254-66.
[PMID: 34415683]
[PMID: 34415683]
[2]
Valdés-Fernández BN, Duconge J, Espino AM, Ruaño G. Personalized health and the coronavirus vaccines-Do individual genetics matter? Bi-oessays 2021 09; 43(9): e2100087.
[PMID: 34309055]
[PMID: 34309055]
[3]
Mariana R Botton, Michelle Whirl-Carrillo, Andria L Del Tredici, et al. PharmVar GeneFocus: CYP2C19. Clin Pharmacol Ther 2021; 2(109): 352-66. View Publication.
[4]
Morales-Borges RH, Gonzalez MJ, Duconge J, Minich DM. N-Acetyl cysteine and glutathione in health and cancer-pharmacogenomics, research, and clinical practice: Hypothesis and review. Altern Ther Health Med 2020 Dec 29;
[PMID: 33373322]
[PMID: 33373322]
[5]
Santiago D, Mangas-Sanjuan V, Melin K, Duconge J, Zhao W, Venkataramanan R. Pharmacokinetic characterization and external evaluation of a quantitative framework of sublingual buprenorphine in patients with an opioid disorder in puerto rico. Pharmaceutics 2020 Dec 18; 12(12)
[PMID: 33352843]
[PMID: 33352843]